Grupo Fleury
Rodrigo Sampaio has extensive experience in finance and accounting roles, currently serving as Gerente de Glosas at Grupo Fleury since March 2021. Previously, Rodrigo held the position of Coordenador Financeiro at CURA grupo from August 2019 to March 2021, where responsibilities included managing the resource of glosas, oversight of accounts receivable, and developing performance indicators. Rodrigo's career at Grupo Fleury began in May 2014, progressing from Analista de Finanças Junior to Sênior, contributing significantly to process improvements and system integration projects. Earlier roles at MED LAR and Hospital Santa Cruz focused on negotiation and performance evaluation within healthcare financing. Rodrigo holds an MBA from FGV, with additional education in negotiation strategies and healthcare-related studies.
This person is not in any teams
This person is not in any offices
Grupo Fleury
1 followers
With almost 100 years, Grupo Fleury is one of the most respected medical and health organizations in Brazil, recognized by the community and public opinion for its technical, medical, service and management excellence. In recent years, it has accelerated its growth towards being an integrated, preventive and hybrid health ecosystem, combining physical and digital offers. With this integrated system, it has increasingly been able to support the physician's clinical conduct in the search for solutions that meet the needs of each patient, while contributing to the sustainability of the system. In addition to diagnostic medicine, it has expanded its activities to the stages of prevention, primary, secondary and tertiary care. With more than 13 thousand employees and 3 thousand doctors, the company is present in the markets of São Paulo, Rio de Janeiro, Rio Grande do Sul, Paraná, Bahia, Pernambuco, Rio Grande do Norte, Maranhão, Espírito Santo and Distrito Federal. The company has established itself as one of the biggest references in best social, economic and environmental practices (Environmental, Social and Governance - ESG). Recently, it was recognized and was included for the second time in the 'Dow Jones Sustainability Index (DJSI)', of the New York Stock Exchange, in the DJSI Emerging Markets portfolio, being the only company in the Health sector in the Americas to be part of of the index.